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Parotoid gland secretions of toad species are a vast reservoir of bioactive molecules with a wide range of
biological properties. Herein, for the ﬁrst time, it is described the isolation by preparative reversed-phase
HPLC and the structure elucidation by NMR spectroscopy and/or mass spectrometry of nine major
bufadienolides from parotoid gland secretions of the Cuban endemic toad Peltophryne fustiger: j-
bufarenogin, gamabufotalin, bufarenogin, arenobufagin, 3-(N-suberoylargininyl) marinobufagin, bufo-
talinin, telocinobufagin, marinobufagin and bufalin. In addition, the secretion was analyzed by UPLC-MS/
MS which also allowed the identiﬁcation of azelayl arginine. The effect of arenobufagin, bufalin and j-
bufarenogin on Naþ/Kþ-ATPase activity in a human kidney preparation was evaluated. These bufadie-
nolides fully inhibited the Naþ/Kþ-ATPase in a concentration-dependent manner, although arenobufagin
(IC50 ¼ 28.3 nM) and bufalin (IC50 ¼ 28.7 nM) were 100 times more potent than j-bufarenogin
(IC50 ¼ 3020 nM). These results provided evidence about the importance of the hydroxylation at position
C-14 in the bufadienolide skeleton for the inhibitory activity on the Naþ/Kþ-ATPase.
Published by Elsevier Ltd.1. Introduction
Isolation of bioactive compounds from venoms represents an
extremely valuable pharmacological approach for the development
of animal toxin-based drugs with high speciﬁcity and potency to-
wards their molecular targets mainly located in the cardiovascular
and nervous systems. As an example, the analgesic properties of the
alkaloid epibatidine, isolated from Epipedobates anthonyi (Daly,
1998; Fitch et al., 2010), is the result of its binding to nicotinic
and muscarinic acetylcholine receptors, while “Chan Su”, a mixtureerera Cordova).
a-Filho who was responsible
deceased precociously andof bufadienolides from Bufo gargarizans and Duttaphrynus mela-
nostictus (also found in literature as Rhinella gargarizans and
Rhinella melanostictus) (Steyn and Heerden, 1998; Chen et al., 2015)
has been widely used as a therapeutic agent in China for stimula-
tion of myocardial contraction or the treatment of tonsillitis, sore
throat, and palpitations. This traditional crude mixture has also
been tested against tumor cell lines and in cancer models (Chan
et al., 1995; Steyn and Heerden, 1998; Takai et al., 2012; Lee et al.,
2014).
Toad venoms are found in skin secretions (Li et al., 2015) and
have been isolated mainly from parotoid glands (Ferreira et al.,
2013; Jing et al., 2013; Sciani et al., 2013) of species from the
Bufonidae family (Daly et al., 2004), although they have not been
detected in theMelanophryniscus genus (Mebs et al., 2007). Usually,
these secretions contain a wide range of molecules, like biogenic
amines, alkaloids, steroids, peptides and high molecular weight
proteins (Rash et al., 2011; Tian et al., 2013; Schmeda-Hirschmann
W.H. Perera Cordova et al. / Toxicon 110 (2016) 27e3428et al., 2014). These molecules play an important physiological role
for anti-microbial defense and against predator attacks (Toledo and
Jared, 1995; Jared et al., 2009; Mailho-Fontana et al., 2014).
Therefore, parotoid gland venoms are considered a promising
reservoir for unexplored active molecules. Among them, cardiac
bufadienolides comprise one of the most interesting groups of
bioactive substances from secretions of amphibians (Kamboj et al.,
2013). They have also been found in reptiles such as the Asian snake
Rhabdophis tigrinus (Hutchinson et al., 2013) as well as in several
plant families (Steyn and Heerden, 1998; Evans, 2002; Mulholland
et al., 2009; Kamboj et al., 2013; Zhang et al., 2014). Bufadienolides
are C-24 steroids having a 2-pyrone ring linked at C-17 (b-oriented)
and a cis fusion for both the A/B and C/D ring junctions, and a trans
fusion for the A/B junction. They are usually characterized by the
presence of a 14-b hydroxyl group. Some bufadienolides have been
pharmacologically assayed in different in vitro and in vivo models
(Slingerland et al., 2013; Schmeda-Hirschmann et al., 2014). They
have shown antitumoral and antiproliferative activity (Tian et al.,
2013; Moreno et al., 2013; Ferreira et al., 2013; Schmeda-
Hirschmann et al., 2014; Wang and Bi, 2014). Some studies have
demonstrated antimicrobial (Cunha-Filho et al., 2010), anti-
leishmanial and antitrypanosomal activity (Tempone et al., 2008).
The pharmacological effects of bufadienolides were reviewed by
Cunha-Filho et al. (2010) and included antiangiogenic, hypertensive
or anti-hypertensive, immunosupression, anti-endometriosis and
positive ionotropic actions. However, the most relevant pharma-
cological effect for these steroids is their speciﬁc inhibition of Naþ/
Kþ-ATPase activity (Bagrov et al., 1998; Touza et al., 2011). Some
studies have been conducted to establish the structure-activity
relationship of bufadienolides as Naþ/Kþ-ATPase inhibitors with
recent advances comprising the description of the bufalin-Naþ/Kþ-
ATPase complex using puriﬁed porcine kidney enzyme (Tian et al.,
2013; Laursen et al., 2015).
Peltophryne fustiger Schwartz, is one of the eight endemic toads
from the Cuban archipelago and it is the biggest species among
Antillean toads of the family Bufonidae (Alonso et al., 2014). It has a
broad distribution in the lowlands and mountains of Western Cuba
(Fig. 1A) from the Guanahacabibes Peninsula to the borders of the
“Llanura de Zapata”, below 390 m elevation (Estrada and Ruibal,
1999). It is a common species that normally inhabits undisturbed
areas such as moist broadleaf forests along stream banks in mesic
situations and coastal tickets, but it is also found in degraded forest
and rural gardens (Díaz and Cadiz, 2008; Henderson and Powell,
2009). Females reach 198.0 mm of snout-vent length, whereas
males are smaller with average of 129.5 mm (Schwartz, 1960). BothFig. 1. (A) Shaded area represents the approximate distribution range of Peltophryne fustiger
adult male of this species, with the arrow indicating the large parotoid gland. Photograph co
reader is referred to the web version of this article.)sexes have large and conspicuous parotoid glands located trans-
versally in a postorbital position on the head (Fig. 1B).
The chemistry of the paratoid gland secretions from Cuban
toads has remained unstudied until now. In this study, we focused
on the isolation and structural elucidation of the major bufadie-
nolides from the parotoid gland secretions of the P. fustiger and the
evaluation of the inhibitory effect of three of them on human kid-
ney Naþ/Kþ-ATPase activity.
2. Materials and methods
2.1. Secretion collection and extraction
Parotoid gland secretions were collected from seven adult male
specimens of P. fustiger in Santo Tomas stream, El Moncada, Vi~nales,
Pinar del Río, Cuba (2233000.800N 8350014.600W) on March, 29,
2014. The secretions were obtained by mechanical compression of
both glands from living individuals. These yellowish and doughy
secretions were collected on a surface of a watch glass. After this
procedure, the individuals were released; only one specimen was
preserved as a voucher and deposited in the Herpetological
Collection of the Museum of Natural History “Felipe Poey”, Faculty
of Biology, University of Havana, Cuba (MFP 11.599).
Fresh secretions (1.45 g) were extracted three times with 80 mL
MeOH by shaking at room temperature. Extract solutions were
pooled, ﬁltered and evaporated under reduced pressure to afford
266 mg of a pale yellowish crude extract.
2.2. HPLC analyses
2.2.1. Analytical conditions
20 mL (2 mg/mL) of crude extract were injected in a RP C-18
Purospher, Merck Millipore (250  4 mm, 5 mm) column at 30 C.
The elution was performed using gradient of 0.1% triﬂuoroacetic
acid (A) and acetonitrile (B) as follows: 0e10 min, 5% B; 10e20 min,
5e40% B; 20e25 min, 40% B; 25e60 min, 40e70% B. The ﬂow rate
was set at 1 mL/min and the chromatogramwas analyzed mainly at
300 nm.
2.2.2. Preparative conditions
250 mg of crude extracts were dissolved in 8 mL of MeOH and
ﬁltered through 0.45 mmMinisart RC 4 ﬁlters. 300 mL of the sample
were successively subjected to preparative HPLC Dionex Ultimate
3000 on a Phenomenex Luna RP-C18 (250 mm  21.2 mm, 10 mm)
by using gradient of elution as follows: 0e10min, 5% B; 10e20 min,in Western Cuba. Red dot indicates the collection locality (B) Details of the head of an
urtesy of J. Bosch. (For interpretation of the references to color in this ﬁgure legend, the
Fig. 2. Analytical RP-C18 HPLC chromatographic proﬁle of crude extract from parotoid
gland secretion of Peltophryne fustiger recorded at 300 nm. (7) Azelayl arginine
(10) j-bufarenogin, (11) gamabufotalin, (12) bufarenogin, (14) arenobufagin, (15) 3-(N-
suberoylargininyl) marinobufagin, (16) bufotalinin, (17) telocinobufagin, (18) mar-
inobufagin, (19) bufalin: UV-spectrum of marinobufagin) (A).
W.H. Perera Cordova et al. / Toxicon 110 (2016) 27e34 295e30% B; 20e25min, 30% B; 25e50min, 30e50% B and 50e55min,
50e100% B. The ﬂow rate was 15 mL/min, and the detection
wavelength was ﬁxed at 300 nm. HPLC analyses led the isolation of
ten compounds: 7 (23.52 min, < 1 mg); 10 (27.02 min, 6.7 mg); 11
(28.82 min, < 1 mg); 12 (29.21 min, 1.8 mg); 14 (34.02 min,
22.2 mg); 15 (39.18 min, < 1 mg); 16 (42.03 min, < 1 mg); 17
(46.0 min, 10.3 mg); 18 (50.02 min, 12.8 mg), 19 (53.3 min, 2 mg).
Compounds 10 and 14 were further puriﬁed by using the same
column and chromatographic conditions to afford both chemicals
with relative purities higher than 97%.
2.3. Spectroscopic and spectrometric analyses
Spectra were recorded on a Bruker Avance 500 NMR spec-
trometer at 298 K, operating at 500.13 MHz for 1H and 125.75 MHz
for 13C using MeOH-d4 and CHCl3-d. Chemical shifts were reported
in d (ppm) relative to tetramethylsilane, used as an internal stan-
dard. Coupling constants were reported as J (Hz) and multiplicities
with abbreviations d, doublet; dd, doublet of doublets and br, broad
signal. HRESIMS and ESI-MS/MS spectra were recorded on an ESI-
Qq-TOF mass spectrometer (micrOTOF-Q III, Bruker) and in a
Bruker Ion Trap Mass Spectrometer respectively, both in the posi-
tive ion mode by direct infusion.
2.4. UPLC-MS/MS analysis
Analyses were performed in an Acquity UPLC system (Waters).
10 mL (1 mg/mL MeOH:H2O (1: 1; v:v) were injected in a RP-C18
(2.1  50 mm, 1.7 mm) Waters Acquity UPLC BEH using a gradient
elution of 0.1% formic acid (A) and acetonitrile (B) 0e8 min
15e100% (B). The ﬂow rate was set at 0.3 mL/min and the chro-
matogram recorded in the range of 190e400 nm. MS data were
measured using an electrospray ionization source coupled to a SQD
system (Waters) in both positive and negative ionization modes:
ESI conditions. Positive mode: capillary (3.5 kV); cone (30 V);
desolvation temp (350 C); desolvation gas (300 L/Hr); sweep gas,
5. Negative mode: capillary (4.0 kV); cone (40 V); desolvation temp
(350 C); desolvation gas (300 L/Hr); sweep gas, 5. Mass range was
set to optimally pass ions from m/z 100e2000.
2.5. Preparation of Naþ/Kþ-ATPase from human kidney
Normal human renal tissues (from the unaffected pole) were
obtained from patients who underwent unilateral nephrectomy
due to well-encapsulated hypernephroma in one kidney pole. All
procedures for the use of discarded organ portions were performed
in accordance with the Institutional Ethical Committee from Hos-
pital Universitario Clementino Fraga Filho, Universidade Federal do
Rio de Janeiro, Brazil.
Crude homogenate preparations were obtained according to
previously described procedures (Quintas et al., 1997; Lopez et al.,
2002). Brieﬂy, the tissue was homogenized in a Potter homoge-
nizer with amotor driven Teﬂon pestle at 4 C in 2e3 volumes of ice
cold 0.25 M buffered sucrose pH 7.4, containing 0.1 mM phenyl-
methylsulfonyl ﬂuoride (PMSF) per gram organ. After centrifuga-
tion at 100,000g for 1 h, pellets were re-suspended with the same
buffer without PMSF and were stored in N2 until use. The protein
concentration was measured according to the method of Lowry
et al. (1951) using bovine serum albumin as the standard.
2.6. Inhibition of Naþ/Kþ-ATPase activity
The Naþ/Kþ-ATPase activity was determined by the Fiske and
Subbarow method (1925) with slight modiﬁcations, as previously
described (Po^ças et al., 2007). The speciﬁc activity of the enzymecorresponds to the difference between the total ATPase activity and
the activity measured in the presence of 1 mM ouabain. The
preparationwas incubated at 37 C for 2 h, in 0.5mL of 84mMNaCl,
3 mM KCl, 3 mM MgCl2, 1.2 mM ATPNa2, 2.5 mM EGTA, 10 mM
sodium azide and 20 mM maleic acid buffered with TRIS to pH 7.4
in the absence or presence of inhibitor(s). Classical concen-
trationeeffect (doseeresponse) curves were performed with each
inhibitor. Crude extract and selected compounds were evaluated
and results were expressed as half-maximal inhibitory concentra-
tion (IC50).
2.7. Statistical analysis
2.7.1. Concentration-effect curves for inhibition of Naþ/Kþ-ATPase
activity
Inhibition curves were ﬁtted using computerized non-linear
regression analysis of the data (Prism®, GraphPad Software Inc.,
version 5.01), assuming a sigmoidal doseeresponse curve model,
where the parameters bottom and top were ﬁxed at 0 and 100%,
respectively, to determine the half maximal inhibitory concentra-
tion (IC50), as previously reported for a similar study (Po^ças et al.,
2007). For illustrative purpose, mean curves form 3e4 indepen-
dent experiments are shown in the ﬁgures but the IC50 values in the
text are expressed as geometric means of the different experiments
with their 95% conﬁdence interval.
3. Results
3.1. Isolation and structure elucidation
The DAD-RP-HPLC chromatographic proﬁle of the crude extract
from parotoid gland secretions of P. fustiger (Fig. 2) was mainly
composed of peaks with UV-spectra, ca. 214 and 300 nm (Fig. 2A)
characteristics of the 2-pyrone chromophore of the bufadienolides
(Liu et al., 2010).
Taking into account that most of the signals showed the char-
acteristic UV spectrum of bufadienolides, and the molar absorp-
tivity of this subfamily of compounds are quite similar, it was
recognized that peaks 14, 17 and 18 represented the major com-
pounds in the crude extracts. The scale up to preparative RP-HPLC
W.H. Perera Cordova et al. / Toxicon 110 (2016) 27e3430was successfully achieved despite the fact that analytical and pre-
parative C-18 stationary phases were manufactured by different
companies. Similar analytical and preparative chromatogramswere
registered. Thus, the application of this methodology allowed the
isolation of ten compounds.
Compounds 10, 12, 14, 17, 18 and 19 were identiﬁed as j-
bufarenogin, bufarenogin, arenobufagin, telocinobufagin, mar-
inobufagin and bufalin, respectively, by comparison of their NMR
and MS data with those previously reported in literature (Kamano
et al., 1998; Ye and Guo, 2005; Ye et al., 2006; Cunha-Filho et al.,
2010). 1H and 13C chemical shifts were unambiguously assigned by
1He1H COSY, HSQC and HMBC, and summarized in Tables 1 and 2.
The minor constituents from the analyzed venom were tentatively
identiﬁed by UPLC-MS/MS, in the positive and negative ion modes
(Table 3), as azelayl arginine (7), gamabufotalin (11), 3-(N-sub-
eroylargininyl)-marinobufagin (15), and bufotalinin (16), by com-
parison of retention times, UV spectra and MS data with those
reported in literature (Gao et al., 2010; Schmeda-Hirschmann et al.,
2014). Chemical structures of the isolated compounds are shown in
Fig. 3.3.2. Inhibition of human kidney Naþ/Kþ-ATPase
The methanolic extract of the P. fustiger venom fully inhibits theTable 1
1H NMR chemical shifts of bufadienolides isolated from parotoid gland secretions of Pelt
1H j-bufarenogin (10)
d ppm
Bufarenogin (12)
d ppm
Arenobufagin (14)
d ppm
1 1.76 (m, 1H)
1.58 (m, 1H)
2.39 (m, 1H)
1.48 (m, 1H)
2 1.87 (m, 1H)
1.68 (m, 1H)
1.72 (m, 1H)
1.51 (m, 1H)
3 4.20 (br, s, 1H) 4.03 (br, s, 1H) 4.13 (br, s, 1H)
4 1.80 (m, 1H)
1.48 (m, 1H)
1.79 (m, 1H)
1.37 (m, 1H)
5 1.88 (m, 1H) 1.86 (m, 1H)
6 1.96 (m, 1H)
1.40 (m, 1H)
1.95 (m, 1H)
1.33 (m, 1H)
7 1.87 (m, 1H)
1.30 (m, 1H)
1.81 (m, 1H)
1.37 (m, 1H)
8 2.37 (m, 1H) 2.02 (m, 1H)
9 2.46 (d, 1H)
J ¼ 12.2 Hz
2.79 (d, 1H) 1.75 (m, 1H)
10 e e e
11 e 4.33 (d, 1H)
J ¼ 11.2 Hz
12 4.11 (s, 1H) 4.06 (s, 1H) e
13 e e e
14 e e e
15 1.68 (m, 1H)
1.55 (m, 1H)
1.75 (m, 1H)
1.35 (m, 1H)
16 1.88 (m, 1H)
1.69 (m, 1H)
2.05 (m, 1H)
1.73 (m, 1H)
17 2.36 (m, 1H) 4.10 (m, 1H)
18 1.05 (s, 3H) 1.24 (s, 3H) 0.93 (s, 3H)
19 1.0 (s, 3H) 0.50 (s, 3H) 1.19 (s, 3H)
20 e e e
21 7.33 (d, 1H)
J ¼ 2.6 Hz
7.46 (d, 1H)
J ¼ 2.6 Hz
7.39 (d, 1H)
J ¼ 2.4 Hz
22 7.49 (dd, 1H)
J ¼ 9.7; 2.6 Hz
7.93 (dd, 1H)
J ¼ 9.8, 2.5 Hz
7.71 (dd, 1H)
J ¼ 9.7; 2.4 Hz
23 6.26 (d, 1H)
J ¼ 9.7 Hz
6.28 (d, 1H)
J ¼ 9.6 Hz
6.29 (d, 1H)
J ¼ 9.7 Hz
24 e e e
Assignments were made by analysis of COSY, HSQC, HMBC and/or NOESY spectra. Overl
Chemical shifts of j-bufarenogin, arenobufagin and bufalin are presented in CHCl3-d whNaþ/Kþ-ATPase activity present in a human kidney membrane
preparation, in a concentration-dependent manner (Fig. 4A), with a
IC50 value of 0.468 mg/ml (95% CI: 0.207e1.060). Particularly, pure
arenobufagin, bufalin and j-bufarenogin isomers also fully inhibit
Naþ/Kþ-ATPase activity (Fig. 4B). However, arenobufagin [IC50
value: 28.3 nM (95% CI: 7.93e101)] and bufalin [IC50 value: 28.7 nM
(95% CI: 13.6e60.5)] were 100 times more potent than j-bufar-
enogin [IC50 value: 3020 nM (95% CI: 2189e4167)].4. Discussion
The composition and pharmacological properties of the secre-
tions from parotoid glands and skin of members of the Bufonidae
family have been studied for a long time (Chen and Chen, 1933).
One of the earlier contributions summarized 50 compounds from
39 species collected from several localities worldwide (Low, 1972).
More than forty years later, herein we present the isolation of the
ﬁrst bufadienolides from Antillean endemic bufonids, speciﬁcally
from the Cuban Giant toad P. fustiger. The compounds (Fig. 3) are
among the most commonly isolated bufadienolides from species of
this family (Cunha-Flho et al., 2005, 2010; Sciani et al., 2013; Qi
et al., 2014). However, only one of them (marinobufagin) has
been identiﬁed in species of the genus Rhaebo (Ferreira et al., 2013),
one of the closest relative lineages of Peltophryne (Van Bocxlaerophryne fustiger.
Telocinobufagin (17)
d ppm
Marinobufagin (18)
d ppm
Bufalin (19)
d ppm
1.81 (m, 1H)
1.38 (m, 1H)
1.83 (m, 1H)
1.40 (m, 1H)
1.49 (m, 1H)
1.42 (m, 1H)
1.70 (m, 1H)
1.59 (m, 1H)
1.65 (m, 1H)
1.61 (m, 1H)
1.58 (m, 1H)
1.52 (m, 1H)
4.14 (br, s, 1H) 4.12 (br, s, 1H) 4.14 (br, s, 1H
2.24 (m, 1H)
1.48 (m, 1H)
2.25 (m, 1H)
1.46 (m, 1H)
1.88 (m, 1H)
1.35 (m, 1H)
e e 1.75 (m, 1H)
1.73 (m, 1H)
1.39 (m, 1H)
1.69 (m, 1H)
1.30 (m, 1H)
1.88 (m, 1H)
1.27 (m, 1H)
1.95 (m, 1H)
1.27 (m, 1H)
1.62e1.60 (m, 2H) 1.72e1.18 (m, 2H)
1.67 (m, 1H) 2.42 (m, 1H)
1.96 (m, 1H)
1.51 (m, 1H)
1.62 (m, 1H) 1.65 (m, 1H) 1.61 (m, 1H)
e e e
1.48 (m, 1H)
1.30 (m, 1H)
1.63 (m, 1H)
1.43 (m, 1H)
1.72e1.18 (m, 2H)
1.52 (m, 1H)
1.46 (m, 1H)
1.72 (m, 1H)
1.51 (m, 1H)
1.49 (m, 1H)
1.39 (m, 1H)
e e e
e e e
2.09 (m, 1H)
1.72 (m, 1H)
3.60 (s. 1H) 2.06 (m, 1H)
1.69 (m, 1H)
2.21 (m, 1H)
1.73 (m, 1H)
1.66 (m, 1H)
1.31 (m, 1H)
2.18 (m, 1H)
1.72 (m, 1H)
2.58 (dd, 1H)
J ¼ 9.4, 6.1 Hz
2.59 (br, d, 1H) 2.46 (m, 1H)
0.73 (s, 3H) 0.74 (s, 3H) 0.70 (s, 3H)
0.95 (s, 3H) 1.0 (s, 3H) 0.95 (s, 3H)
e e e
7.45 (d, 1H)
J ¼ 2.4 Hz
7.48 (d, 1H)
J ¼ 2.4 Hz
7.24 (d, 1H)
J ¼ 2.6 Hz
8.01 (dd, 1H)
J ¼ 9.7, 2.3 Hz
7.90 (dd, 1H)
J ¼ 9.7, 2.4 Hz
7.85 (dd, 1H)
J ¼ 9.7, 2.6 Hz
6.30 (d, 1H)
J ¼ 9.7 Hz
6.26 (d, 1H)
J ¼ 9.7 Hz
6.26 (d, 1H)
J ¼ 9.7 Hz
e e e
apping signals are reported without designating multiplicity.
ereas for bufarenogin, telocinobufagin, marinobufagenin are shown in MeOH-d4.
Table 2
13C NMR chemical shifts in CHCl3-d and MeOH-d4 of ﬁve bufadienolides isolated from parotoid gland secretions of P. fustiger.
13C j-bufarenogin (10)
d ppm
Arenobufagin (14)
d ppm
Telocinobufagin (17)
d ppm
Marinobufagin (18)
d ppm
Bufalin (19)
d ppm
CHCl3-d MeOH-d4 D CHCl3-d MeOH-d4 D CHCl3-d MeOH-d4 D CHCl3-d MeOH-d4 D CHCl3-d MeOH-d4 D
1 29.65 29.51 þ0.14 31.72 31.59 þ0.13 24.82 24.72 þ0.10 24.76 24.64 þ0.12 29.62 29.40 þ0.22
2 28.22 27.55 ¡0.67 28.63 27.74 þ0.89 27.96 27.07 þ0.89 27.91 27.06 þ0.85 27.86 27.13 þ0.73
3 66.47 65.95 þ0.52 66.79 66.37 þ0.42 68.08 67.66 þ0.42 68.0 67.61 þ0.39 66.85 66.27 þ0.58
4 33.98 33.13 þ0.85 33.49 33.04 þ0.45 36.86 36.32 þ0.54 36.85 36.28 þ0.57 33.26 32.75 þ0.51
5 36.17 36.38 ¡0.21 37.59 37.79 ¡0.20 74.64 74.78 ¡0.14 74.62 74.39 þ0.23 35.96 36.02 ¡0.06
6 26.88 26.88 e 26.34 26.28 þ0.06 35.31 34.53 þ0.78 34.65 33.75 þ0.90 26.51 26.47 þ0.04
7 20.74 20.61 þ0.13 21.69 21.34 þ0.35 23.81 23.38 þ0.43 23.25 22.56 þ0.69 21.40 21.17 þ0.23
8 39.29 39.45 ¡0.16 39.71 39.29 þ0.42 41.44 40.60 þ0.84 32.60 31.73 þ0.87 42.33 41.60 þ0.73
9 46.45 46.34 þ0.11 40.62 39.90 þ0.72 39.23 38.74 þ0.49 42.73 42.42 þ0.31 35.37 35.06 þ0.31
10 38.38 37.64 þ0.74 37.04 36.72 þ0.32 40.92 40.50 þ0.42 40.87 40.60 þ0.27 35.67 35.45 þ0.22
11 214.27 214.40 ¡0.13 73.45 73.78 ¡0.33 21.77 21.60 þ0.17 21.42 21.24 þ0.18 21.40 21.17 þ0.23
12 82.57 82.56 ¡0.01 213.74 213.76 ¡0.02 40.92 40.50 þ0.42 39.38 38.67 þ0.71 40.91 40.54 þ0.37
13 54.29 54.30 ¡0.01 61.75 62.47 ¡0.72 49.09 47.58 þ1.51 45.04 44.73 þ0.31 48.36 48.37 ¡0.01
14 83.18 82.92 þ0.26 85.71 85.05 þ0.66 84.47 84.65 ¡0.18 74.76 74.68 þ0.08 85.39 84.76 þ0.63
15 33.79 33.32 þ0.47 32.92 31.74 þ1.18 32.66 31.73 þ0.93 59.77 59.77 e 32.71 31.79 þ0.92
16 27.33 27.21 þ0.12 27.93 27.64 þ0.29 28.58 28.36 þ0.22 32.31 32.67 ¡0.36 28.73 28.46 þ0.27
17 45.48 45.54 ¡0.06 40.83 40.51 þ0.32 51.06 50.69 þ0.37 47.58 47.24 þ0.34 51.21 50.88 þ0.33
18 19.39 17.87 þ1.52 17.45 16.72 þ0.73 16.44 15.83 þ0.61 16.76 15.64 þ1.12 16.53 15.93 þ0.60
19 24.26 23.39 þ0.87 23.38 22.58 þ0.80 16.69 15.83 þ0.86 16.76 15.85 þ0.91 23.73 22.91 þ0.82
20 118.96 120.31 þ1.55 120.46 121.97 ¡1.51 122.35 123.62 ¡1.27 122.14 123.09 ¡0.95 122.78 123.67 ¡0.89
21 150.66 151.13 þ0.47 150.04 150.24 ¡0.20 148.60 149.09 ¡0.49 149.58 150.37 ¡0.79 148.52 149.04 ¡0.52
22 146.95 148.41 þ1.46 146.38 148.09 ¡1.71 146.62 147.96 ¡1.34 146.91 148.16 ¡1.25 146.90 147.99 ¡1.09
23 114.66 113.11 þ1.55 115.77 114.48 þ1.29 115.42 114.02 þ1.40 115.33 113.96 þ1.37 115.27 114.02 þ1.25
24 162.03 163.22 ¡1.19 162.06 163.71 ¡1.65 162.78 163.44 ¡0.66 162.04 163.09 ¡1.05 162.49 163.43 ¡0.94
D: Difference between chemical shifts in CHCl3-d e MeOH-d4; Assignments were made by analysis of COSY, HSQC, and HMBC spectra.
Bold means difference in chemical shifts higher than 0.5 ppm.
Table 3
Tentative identiﬁcation of minor constituents from Peltophryne fustiger venom by UPLC-MS/MS in the negative and positive ionmodes based on Gao et al. (2010) and Schmeda-
Hirschmann et al. (2014).
Compound [MH] [MþH]þ UV trace Tentative identiﬁcation Main fragmentsa
7 343.2 345.3 No
bufadienolide
Azelayl arginine 250.2; 175.1 (arginine)
11 403.3 Bufadienolide Gamabufotalin 425.3 (M þ Na); 385.4 (M þ HeH2O); 331.3 (385e2x H2O)
15 711.5 713.1 Bufadienolide 3-(N-suberoylargininyl) Marinobufagin
(Marinobufotoxin)
695.7 (M þ HeH2O); 331.3; 287.3; 250.2; 175.2 (arginine)
16 413.2 415.2 Bufadienolide Bufotalinin 437.3 (M þ Na); 397.3 (M þ HeH2O); 385.4 (M þ HeH2CO);
331.3
a Positive ion mode: (MS/MS).
W.H. Perera Cordova et al. / Toxicon 110 (2016) 27e34 31et al., 2010; Alonso et al., 2012). To the best of our knowledge, this is
the ﬁrst report about toad venoms showing arenobufagin as the
major compound.
The IC50 values obtained for arenobufagin and bufalin were
similar to those previously reported by us for telocinobufagin
(Touza et al., 2011) all tested with human kidney enzyme under the
same experimental conditions (Table 4), and also equivalent to the
value reported for bufalin using a porcine kidney enzyme prepa-
ration (Laursen et al., 2015). These authors also described the
structure of the bufalin-porcine kidney Naþ/Kþ-ATPase complex in
the presence of Kþ (Laursen et al., 2015). This complex is structur-
ally similar to the digoxin-Naþ/Kþ-ATPase complex obtained in the
same work, and also to the ouabain-Naþ/Kþ-ATPase complex
described previously (Laursen et al., 2013), indicating a similar
mechanism of Naþ/Kþ-ATPase inhibition by cardenolides and
bufadienolides. Speciﬁcally, the hydroxyl substituent at C-14 of
bufalin (highly conserved among bufadienolides) is within
hydrogen-bond distance to Thr797 (aM6) and further stabilized by
Asp121 (aM2) in the porcine enzyme complex. With respect to the
lactone group, the six-membered lactone of bufalin reached deeper
into the cation-binding site of the porcine enzyme than ouabain
and digoxin (Laursen et al., 2013, 2015). This binding mode forbufalin indicated the relevance of the hydroxyl at C-14 and the six-
membered lactone moiety, in the inhibition of the porcine Naþ/Kþ-
ATPase. Since human and porcine Naþ/Kþ-ATPase share 98.1% of
sequence identity, the inhibition of the human kidney enzyme by
bufalin, telocinobufagin and arenobufagin (bufadienolides sharing
similar IC50 values) probably follow a similar mechanism to that
described for the interaction of bufalin with the porcine enzyme.
Moreover, the substitution of the OH at C-14 (well conserved in
the bufadienolide family) in marinobufagin by an epoxy group
comprising cyclization of hydroxyl group between C-14 and C-15,
also has a profound negative effect on the inhibition of the human
kidney enzyme with IC50 value around 25e40 fold higher in com-
parison with arenobufagin, bufalin and telocinobufagin (Touza
et al., 2011) (Table 4). These results are in good agreement with
the binding mode of bufalin:porcine kidney Naþ/Kþ-ATPase
complex.
Additionally, the results suggest that the presence of a ketone
group at C-12 and a hydroxyl at C-11 on arenobufagin had no effect
on the inhibitory potency regarding bufalin and telocinobufagin.
However, interchanging the position of these two substituents
promotes an important decrease in the inhibitory potency, since
the IC50 of j-bufarenogin was 100-fold higher (Table 4). We can
Fig. 3. Chemical structures of the compounds from P. fustiger. The numbers correspond with the elution order in the analytical RP-C18 column as in Fig. 2: (7) Azelayl arginine (10)
j-bufarenogin, (11) gamabufotalin, (12) bufarenogin, (14) arenobufagin, (15) 3-(N-suberoylargininyl) marinobufagin, (16) bufotalinin, (17) telocinobufagin, (18) marinobufagin, (19)
bufalin.
Fig. 4. Inhibition curves of Naþ/Kþ-ATPase activity from human kidney preparation: (A) methanolic extract from parotoid gland secretion from P. fustiger; (B) bufalin, arenobufagin,
and j-bufarenogin. Results (mean ± SEM) were expressed as percent of the inhibition measured in the presence of 1 mM ouabain; A (n ¼ 4) and B (n ¼ 3).
W.H. Perera Cordova et al. / Toxicon 110 (2016) 27e3432hypothesize that the more rigid ketone group at C-11 position in j-
bufarenogin is less well accommodated in the enzyme in compar-
ison with the same group on C-12 position in arenobufagin.5. Conclusions
The chemical analyses of parotoid gland secretions of the
Table 4
Summary of the substituents on the steroid core of different bufadienolides, and their corresponding IC50 for inhibition of Naþ/Kþ-ATPase enzymatic activity from human
kidney.
Bufadienolide Substituents at the steroid core IC50 (nM) Reference
3b 5b 11 12 14b 19b
arenobufagin OH H a-OH C]O OH CH3 28.3 Present work
bufalin OH H H H OH CH3 28.7 Present work
Ѱ-bufarenogin OH H C]O b-OH OH CH3 3020 Present work
marinobufagin OH OH H H 14-O-15 epoxide CH3 1144 Touza et al., 2011
telocinobufagin OH OH H H OH CH3 44.2 Touza et al., 2011
In all cases, the IC50 values were determined under the same experimental conditions in presence of 3.0 mM KCl.
W.H. Perera Cordova et al. / Toxicon 110 (2016) 27e34 33Western Giant toad P. fustiger from Cuba led the isolation and
structure elucidation of the metabolites azelayl arginine, j-bufar-
enogin, gamabufotalin, bufarenogin, arenobufagin, 3-(N-sub-
eroylargininyl) marinobufagin, bufotalinin, telocinobufagin,
marinobufagin and bufalin. This is the ﬁrst report of the occurrence
of bufadienolide steroids and azelayl arginine not only in the P.
fustiger, but also among the Antillean toads of this genus. It is also
noteworthy that arginine bufadienolide esters are present only in
very small amounts. Arenobufagin, the main component of the
secretion, showed a potent inhibition of human kidney Naþ/Kþ-
ATPase (IC50 in the nM range). The integration of the present data
with recent ﬁndings on the structure of the bufalin-porcine enzyme
complex conﬁrms that the presence of a hydroxyl group at position
C-14 in bufadienolides (also conserved in cardenolides), is highly
important for a tight binding of these compounds to the Naþ/Kþ-
ATPase.
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